About Woosung Pharmaceutical
Woosung Pharmaceutical is a Healthcare company based in Suwon (South Korea) founded in 2015, and was acquired by Shinlazen in March 2025. Drugs for multiple therapeutic areas are manufactured through RD focus. Its chief executive, as recorded, is Cho Hwan woo. Its focus areas include Diversified Pharmaceuticals.
Company details
Woosung Pharmaceutical was established in 2015 in Suwon-si, South Korea. Operations are centered in the pharmaceutical sector, where research and development activities are conducted to produce drugs across various therapeutic areas. Manufacturing processes are emphasized to support drug production. The company is led by CEO Cho Hwan woo, with domain presence at woosung-pharma.com.
- Headquarters Suwon, South Korea
- Stage Acquired
- SectorsHealthcare
- Website woosung-pharma.com
- Acquired by Shinlazen (Mar 2025)
Investors in Woosung Pharmaceutical
Woosung Pharmaceutical has secured backing from 2 investors. Prominent investors backing the company include Corentec and Shinlazen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Portfolio of Hip, Knee & Spinal implants | 2000 | corentec.com | Irvine, United States | |
| shinlazen.tcc.mode |
Investor details for Woosung Pharmaceutical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Woosung Pharmaceutical
1 people are tracked at Woosung Pharmaceutical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Cho Hwan woo | CEO | Leadership |
Complete people profiles for Woosung Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Woosung Pharmaceutical
3 dated milestones of Woosung Pharmaceutical across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Woosung Pharmaceutical is founded.
- Exit Acquired by Corentec.
- Exit Acquired by Shinlazen.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Woosung Pharmaceutical
Complete news archive for Woosung Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Woosung Pharmaceutical
Woosung Pharmaceutical was founded in 2015.
Woosung Pharmaceutical is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.
Cho Hwan woo is the CEO of Woosung Pharmaceutical, as recorded in our data.
Woosung Pharmaceutical was established in 2015 in Suwon-si, South Korea. Operations are centered in the pharmaceutical sector, where research and development activities are conducted to produce drugs across various therapeutic areas. Manufacturing processes are emphasized to support drug production. The company is led by CEO Cho Hwan woo, with domain presence at woosung-pharma.com.
Woosung Pharmaceutical has 2 investors. Key investors include Corentec, and Shinlazen.
Yes. Woosung Pharmaceutical was acquired by Shinlazen in March 2025.